ArticleClinical orthopaedics and related research2018
CORR® Tumor Board: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Megan E Anderson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.